Loading stock data…
$7.21-0.17 (-2.24%)
The Joint Corp.
The Joint Corp. in the Healthcare sector is trading at $7.21 with a market capitalization of $118M. Wall Street consensus targets $10.00 (3 analysts), implying a +38.8% move over the next 12 months. The stock is currently near its 52-week low of $6.79, remaining 16.7% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $15.18M↑ | $14.82M↓ | $15.17M↑ | $13.38M↑ | $13.27M |
| Gross Profit | $12.70M↑ | $12.10M↓ | $12.35M↑ | $10.72M↑ | $10.50M |
| Operating Income | -$160,564↓ | $898,995↑ | $743,895↑ | $160,915↑ | -$1.13M |
| Net Income | $653,021↓ | $1.30M↑ | $991,097↑ | $855,009↑ | $93,363 |
The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor mana...